Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified non-natural NKG2D ligands that selectively deliver attached heterologous molecules to non-natural NKG2D receptors on car-cells

Modified non-natural NKG2D ligands that selectively deliver attached heterologous molecules to non-natural NKG2D receptors on car-cells

US Patent 11440948 · Granted Sep 13, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Orthogonal IL-21 receptor/cytokine systems2025
Chimeric protein comprising an anti-influenza virus antibody moiety and a mucoad2025
Compositions for preventing or treating coronavirus infections2025
Modified A1-A2 domains of non-natural NKG2D ligands that bind non-natural NKG2D 2024
Transgenic animals and methods of use2024
Animal model for SARS-CoV-2-spike induced coagulopathy2024
Engineered human IL-21 cytokines and methods for using the same2024
Non-natural NKG2D receptors that do not directly signal the cells to which they 2024
Compositions and methods for reactivating latent immunodeficiency virus using a 2023
Enhanced production of immunoglobulins2021
Transgenic animals and methods of use2021
Enhanced immunoglobulin diversity2020